PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11872207-1	2002	OBJECTIVE: To investigate the effect of an angiotensin-converting enzyme inhibitor, lisinopril, on serum androgen and sex-hormone-binding globulin (SHBG) levels in hypertensive women with polycystic ovary syndrome (PCOS).	Lisinopril	84-94	sex hormone binding globulin	Homo sapiens	118-146	
9877521-0	1998	Lisinopril decreases plasma free testosterone in male hypertensive patients and increases sex hormone binding globulin in female hypertensive patients.	Lisinopril	0-10	sex hormone binding globulin	Homo sapiens	90-118	
9877521-4	1998	Lisinopril had no effect on plasma T, f-T, or E2 concentrations in female patients, but significantly increased the plasma SHBG concentration (before, 48.0 6.1 nmol/l; after, 62.7+/-6.7 nmol/l: p < 0.01).	Lisinopril	0-10	sex hormone binding globulin	Homo sapiens	123-127	
9877521-5	1998	The results of this preliminary study suggest that lisinopril affects plasma f-T and SHBG concentrations.	Lisinopril	51-61	sex hormone binding globulin	Homo sapiens	85-89	
9877521-6	1998	The clinical implications of lisinopril-induced changes in plasma f-T and SHBG concentrations remain to be clarified.	Lisinopril	29-39	sex hormone binding globulin	Homo sapiens	74-78	
11872207-1	2002	OBJECTIVE: To investigate the effect of an angiotensin-converting enzyme inhibitor, lisinopril, on serum androgen and sex-hormone-binding globulin (SHBG) levels in hypertensive women with polycystic ovary syndrome (PCOS).	Lisinopril	84-94	sex hormone binding globulin	Homo sapiens	148-152	
11872207-9	2002	CONCLUSION(S): Use of lisinopril, an angiotensin-converting enzyme inhibitor, results in decreased free T levels independently of SHBG.	Lisinopril	22-32	sex hormone binding globulin	Homo sapiens	130-134